First-in-Human Study of an Oral Plasmodium Falciparum Plasma Membrane Protein Inhibitor

NCT02661373 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
44
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

St. Jude Children's Research Hospital

Collaborators